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1. Introduction 
Several radioimmunoassays for the measurement 
of thyrotropin-releasing hormone (pGlu-His-Pro- 
NHI, TRH) have been described. Antisera have been 
produced mainly by immunization of rabbits with 
TRH-protein conjugates in which coupling was 
effected via the imidazole of the histidyl moiety of 
TRH. For this purpose bis-diazotized benzidine has 
been most widely used [ 11. In another procedure 
TRH is reacted with p-diazoniumphenylacetic acid 
and the derivative is coupled to protein with the aid 
of a carbodiimide [2,3] . An entirely different approach 
has been the introduction of an amide bond between 
pGlu-His-Pro-OH and NH2 -groups of a protein 
carrier resulting in the formation of a TRH-like struc- 
ture, i.e., pGlu-His-Pro-NH-protein [4]. 
We here report the attachment of TRH to hemo- 
cyanin (HC) using the bifunctional reagent 1 ,S-difluoro- 
2,4-dinitrobenzene (DFDNB) [5]. Administration of 
the conjugate to rabbits elicited the production of 
antisera, which were used in the radioimmunoassay of 
the hypothalamic hormone. 
2. Materials and methods 
2.1. Materials 
TRH and luteinizing hormone-releasing hormone 
(LH-RH) were obtained by courtesy of Dr M. von der 
Ohe, Hoechst, Frankfurt, FRG. Another preparation 
of TRH and pGlu-His-Pro-OH were donated by 
Professor Dr H. C. Beyerman and Dr J. L. M. Syrier, 
Technische Hogeschool, Delft, The Netherlands. Both 
tripeptides were also purchased from Beckman Bio- 
products, Geneva, Switzerland. Professor Beyerman 
and Dr Syrier supplied us in addition with pGh- 
fl Bzl-His-Pro-NH* (Bzl, benzyl), pGlu-Nti Bzl- 
His-Pro-OH and pGlu-Nim Bzl-His-Pro-OCHs . 
pGlu-His-OH, pGlu-His-0CH3 and Glu-His-Pro- 
OH were kindly provided by Drs R. 0. Studer and 
D. Gillessen, Hoffman-LaRoche Basle, Switzerland. 
His-Pro-NH2 was a gift of Dr A. 0. Geiszler, Abbott 
Laboratories, North Chicago, IL, USA. Glu-His-Pro- 
NH2, pGlu-Phe-Pro-NH, and pGlu-His-Pro-Gly- 
NH2 were purchased from Peninsula Laboratories, 
San Carlos, CA, USA; [3H]TRH from New England 
Nuclear, Dreieichenhain, FRG; DFDNB from Sigma, 
St. Louis, MO, USA and keyhole limpet HC from 
Calbiochem, Lucerne, Switzerland. 
2.2. Preparation of conjugate 
Bridging of TRH to HC by means of a dinitlo- 
phenylene (DNP) moiety was carried out essentially 
according to the method described by Tager [5] . In 
brief, to 2.5 mg TRH in 0.2 ml 0.1 M phosphate, 
pH 7.2, were added 30 mg DFDNB in 1 ml methanol. 
After reaction for 15 min at 22’C, excess reagent was 
removed by several washings with ether. To the 
aqueous phase containing Nfi -(5-fluoro-2,4-dinitro- 
phenyl)TRH (FDNF-TRH) was added 25 mg HC in 
0.8 ml 0.1 M borate, pH 10.0. The mixture was 
stirred 24 h at 22’C and the TRH-DNP-HC complex 
was dialyzed exhaustively against water. From the 
recovery of simultaneously reacted [3H]TRH it was 
calculated that over 50% of added TRH had reacted 
with HC, which means that over 450 molecules TRH 
were attached to each molecule HC. 
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2.3. Immunization 
Four New Zealand white rabbits were immunized 
with 0.5 mg TRH-DNP-HC in 2 ml water emulsion 
in complete Freund’s adjuvant (1: 3, v/v). Injections 
were given both sub- and intracutaneously at multiple 
sites on the back at intervals of 11 and 9 weeks. 
2.4. Radioiodination and radioimmunoassay of TRH 
Labelling of TRH with “‘1 and radioimmunological 
procedures were performed essentially as previously 
described [3]. 
3. Results 
3.1. Generation of antibodies to TRH 
TWO (Nos. 4094 and 4101) out of the 4 rabbits 
responded to the immunization by developing anti- 
bodies to TRH as demonstrated by significant binding 
of ‘251-labelled TRH to these sera at a final dilution 
of 1 : 1000 or higher. The antisera used in this study 
were obtained 2 weeks (4101) and 4 weeks (4094) 
after the 3rd injection. Binding of ‘2SI-labelled TRH 
(20 000 cpm, < 20 pg/assay tube) to the antisera 
amounted to approx. 30% at final dilution 1 : 7500 
and 1 : 15 000, respectively. 
3.2. Radioimmunoassay of TRH and specificity of the 
antisera 
. Figure 1 shows a typical standard curve for TRH 
of an assay employing antiserum 4094. Very similar 
results were obtained when antiserum 4101 was used. 
The sensitivity of the radioimmunoassays was found 
to be approx. lo-25 pg/assay tube (final volume, 
1 ml). In fig.1 dose-response curves for several 
analogues are also displayed. The relative affinities of 
the various compounds in both assays are depicted in 
table 1. In addition the properties are summarized of 
an antiserum (No. 3 158) raised against a conjugate in 
which TRH was coupled to bovine thyroglobulin 
after derivatization with p-diazoniumphenylacetic 
acid as previously described [3] . 
4. Discussion 
The main feature of the coupling of TRH to pro- 
teins with DFDNB is the use of a large excess of the 
38 
pg pptia/ .asay tube (1 ml) 
Fig.1. Digplacement of ‘251-labelled TRH from antiserum 
4094 (final dilution, 1: 15 000) by increasing concentrations 
of TRH (o), Glu-His-Pro-NH, (.), His-Pro-NH, (D), 
pGlu-N’mBzl-His;Pro-NH, (m), pGlu-N’mBzl-His-Pro- 
OCH, (a), pGlu-N’mBzl-His-Pro-OH (o), LH-RH (*), 
pGlu-Phe-Pro-NH, (X) and pGlu-His-Pro-Gly-NH, (+). 
bifunctional reagent to convert the hormone into a 
Nh-FDNP derivative, thereby assuring a high degree 
of reaction and minimizing dimerization of the tri- 
peptide [5]. Furthermore, conditions are chosen 
which preclude hydrolysis of the reagent [S] . Follow- 
ing the removal of unreacted DFDNB, the coupling 
of FDNP-TRH to HC is accomplished with a mini- 
mum of side reactions [S] . The method involving 
DFDNB has therefore some distinct advantages over 
hitherto described techniques [l-4] for the prepara- 
tion of TRH-protein conjugates. 
An important difference between the methods is 
that reaction of the diazonium reagents with TRH 
involves the carbon atoms of the imidazole [6] as is 
the case with iodination of the hormone [7] , while 
reaction with DFDNB takes place at one of the 
nitrogens [8]. Despite this difference in site of attach- 
ment of TRH to the protein carrier, the properties of 
the antisera raised against the two types of conjugate 
are almost identical (table 1). Deamidation of TRH 
(pGlu-His-Pro-OH), deletion of one of the terminal 
residues (pClu-His-OH and His-Pro-NH,), hydro- 
lysis of the lactam of the pyroglutamyl moiety 
(Glu-His-Pro-NH2) and replacement of Pro-NH* 
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Table 1 
Cross-reactivity of various TRH analogues with anti-TRH antisera 
Analogue Cross-reactivity (%)a 
Antiserum Antiserum Antiserum 
4094b 4101b 3158b 
pGlu-His-Pro-NH, (TRH) 100 100 100 
Glu-His-Pro-NH, 3.3 4.0 2.4 
pClu-His-Pro-OH <0.005 <0.005 <0.025 
Glu-His-Pro-OH <0.005 <0.005 <0.025 
His-Pro-NH, 0.006 0.006 0.025 
pGlu-His-OH <o.oos <0.005 <0.025 
pGh-HissOCH, <0.005 <0.005 <0.025 
pGlu-N, rmBzl-His-Pro-NH, 560 1100 560 
pGh-N!mBzl-His-Pro-OCH, 11.6 0.8 3.1 
pGlu-N’mBzl-His-Pro-OH 0.11 0.03 0.13 
pGlu-His-Trp-Ser-Tyr-Gly-Leu- 
Arg-Pro-Gly-NH, (LH-RH) 0.02 0.02 <0.05 
pGlu-Phe-Pro-NH, 460 580 460 
pGlu-His-Pro-Gly-NH, 2.6 4.6 2.1 
aCross-reactivity is defined as the ratio (X 100) of the concentration of TRH 
over that of the analogue both of which displace 50% of ‘*SI-labelled TRH from 
the antiserum 
b4094, antiserum raised against TRH-DNP-HC; final dilution, 1:15 000 4101, 
antiserum raised against TRH-DNP-HC; final dilution, 1:7500 3158, antiserum 
obtained as described [ 31 ; final dilution 1:2000 
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by Pro-Gly-NH* (pGlu-His-Pro-Gly-NHZ) or by 
an octapeptide chain (LH-RH) result in an almost 
complete loss of immunoreactivity. 
Substitution of the imidazole in TRH and TRH- 
OH with a benzyl-group (~CIU-N~ Bzl-His-Pro- 
NH2 and pGlu-I@Bzl-His-Pro-OH) and replace- 
ment of His by Phe (pClu-Phe-Pro-NH2) favours 
the interaction of the peptides with all antisera to a 
large extent. The cross-reactivity of pGlu-I@” Bzl- 
His-Pro-NH2 with antiserum 3 158 is higher than 
previously reported [3] . However, the antiserum used 
in the present study was obtained approx. 18 months 
later than that previously employed. These results 
seem to indicate that the relative affinity of the benzyl- 
derivative has increased in the course of subsequent 
immunizations. 
The much higher activity of pGlu-@‘Bzl-His- 
Pro-NH* compared with TRH may be caused by its 
closer resemblance with the structural arrangement of 
the haptens in the conjugates. The aromatic moiety 
attached to the imidazole of TRH is therefore likely 
to be part of the antigenic determinant in the TRH- 
protein complex. It is also possible that the basicity 
of the imidazole in the TRH-protein conjugates is 
decreased because of the electron-withdrawing prop- 
erties of the bridging moiety. This may at least in part 
explain the high affinities not only of the @‘Bzl 
derivatives but also of pGlu-Phe-Pro-NH*. 
From our findings it is expected that the Nim -DNP 
derivative of TRH will possess even higher activity 
towards antisera 4094 and 4101. Since this derivative 
can easily be obtained, studies are now in progress in 
our laboratory in order to increase the sensitivity of 
the radioimmunoassay by prior conversion of TRH 
into this compound and by using analogous derivatives 
for labelling with 12’I. 
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